博瑞医药 (688166)
BrightGene Bio-Medical Technology Co., Ltd.
K-Line Chart
No K-line data available
Company NameBioray Laboratories (Suzhou) Co., Ltd.
Listing Date2019-11-08
Issue Price12.71RMB
Registered Capital42246.951610k RMB
Legal RepresentativeJian Dong Yuan
Registered AddressBuilding C25, Nano Science Park, No. 218 Xinghu Street, Suzhou Industrial Park, Jiangsu Province, China
IndustryChemical Pharmaceuticals
Main BusinessEngaged in the research, development, and production of high-tech-barrier pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms.
Company ProfileBioray Laboratories (Suzhou) Co., Ltd. is a research-driven high-tech pharmaceutical company dedicated to the R&D and production of innovative new drugs and high-end generic drugs. Leveraging its professional product development and commercialization capabilities, it provides patients with products of outstanding value.
With the goal of 'Continuous Innovation, Protecting Health,' Bioray seeks solutions for unmet clinical needs. Through years of sustained R&D and exploration, Bioray has achieved breakthroughs in targeted cancer therapy, immunotherapy, as well as in the treatment of fatty liver disease and diabetes. Several innovative drugs have entered or are about to enter clinical studies. Bioray has successfully developed high-end generic drugs such as Eribulin, Trabectedin, and Fondaparinux Sodium, establishing globally competitive product pipelines in areas including oncology, super antibiotics, and intravenous iron supplementation.
Stock Details
1. Key Indicators
- Total Shares(W): 734059.07
- Circulating A-Shares(W): 734059.07
- Earnings Per Share(RMB): 1.23
- Net Assets Per Share(RMB): 5.67
- Operating Revenue(W RMB): 1345261.60
- Total Profit(W RMB): 1345261.60
- **Net Profit Attributable to Parent(W RMB) **: 1345261.60
- Net Profit Growth Rate(%): -55.89
- Weighted Return on Equity(%): 4.6500
- Operating Cash Flow Per Share(RMB): 1.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- New energy vehicle manufacturing and sales
- Intelligent transportation system R&D
- Fuel cell technology development
- Autonomous driving solutions
3. Company Basic Information
- Company Name: Dongfeng Automobile Co., Ltd.
- Listing Date: 2001-05-18
- Industry: Automobile Manufacturing
- Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: https://www.dongfeng.com.cn/
- Company Profile: The company was primarily established by Beijing Capital Venture Group, focusing on automobile manufacturing and related technology R&D, and is one of the leading domestic automobile enterprises.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Securities Finance Co., Ltd. | National Team | 5000 | 10.2 |
| 2 | China Asset Management Co., Ltd. | Public Fund | 3200 | 6.5 |
| 3 | Hillhouse Capital Management | Private Equity Fund | 2800 | 5.7 |
| 4 | National Social Security Fund | National Team | 2500 | 5.1 |
| 5 | E Fund Management Co., Ltd. | Public Fund | 2000 | 4.1 |
| 6 | China Universal Asset Management Co., Ltd. | Public Fund | 1800 | 3.7 |
| 7 | CITIC Securities Co., Ltd. | Broker | 1500 | 3.1 |
| 8 | Guotai Junan Securities Co., Ltd. | Broker | 1200 | 2.4 |
| 9 | China Merchants Bank Co., Ltd. | Bank | 1000 | 2.0 |
| 10 | ICBC Credit Suisse Asset Management Co., Ltd. | Public Fund | 900 | 1.8 |
5. Concept Sectors
- Carbon Neutrality
- Intelligent Transportation
- Fuel Cell
- Autonomous Driving
- New Energy Vehicles
- Hydrogen Energy
- Huawei Auto
- Internet of Vehicles
Remarks
- Data update date: 2025-11-02
- Data source: Public Market Information